BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36927924)

  • 21. [Case report of two colorectal cancer patients with liver metastasis showing favorable response to fluorouracil and l-leucovorin therapy].
    Katsumata K; Ichimiya H; Wakana Y; Okada K; Kato K; Aoki T
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):623-5. PubMed ID: 15114713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A Case of Rectal Cancer and Multiple Liver Metastases Treated Using mFOLFOX and Bevacizumab under Maintenance Dialysis].
    Aimono Y; Kamoshida T; Okawara A; Ogawa T; Suzuki S; Sakamoto R; Saito Y; Aoyama Y
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):985-987. PubMed ID: 30026428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of metastatic colorectal cancer with icterus due to multiple liver metastases treated effectively by FOLFOX plus bevacizumab].
    Terasawa T; Koja S; Yasuda K; Fukuda K
    Gan To Kagaku Ryoho; 2013 Aug; 40(8):1115-8. PubMed ID: 23986063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of long-term survival in a patient with rectal cancer with virchow lymph node metastasis, liver metastases, and lung metastases].
    Oyanagi H; Kameyama H; Nogami H; Shimada Y; Nakano M; Nakano M; Ishikawa T; Sakata J; Kobayashi T; Minagawa M; Kosugi S; Koyama Y; Wakai T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1674-6. PubMed ID: 25731292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A successfully resected case of rectal cancer with liver metastases treated with mFOLFOX6 and bevacizumab].
    Fujita T; Kawasaki K; Ohno M; Kanaji S; Kobayashi I; Ueno K; Tsuchida S; Osawa M; Fujino Y; Kanbara Y; Nakamura T
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):663-6. PubMed ID: 19381044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of resected rectal cancer with hepatic node and multiple liver metastases effectively treated by preoperative modified FOLFOX6 and sLV5FU2 chemotherapy].
    Seshimo K; Oishi M; Toshima T; Ikeda H; Kato H; Yamamura M; Kodera M; Yamashita Y; Tanaka N; Fujita H; Shibagaki K; Taniguchi H; Matsuki T; Kobayashi K; Takita K
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):477-80. PubMed ID: 22421784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of unresectable advanced rectal cancer with liver metastases by hemostasis re-irradiation of the rectal cancer and palliative low-dose whole-liver radiation therapy: a case report.
    Yasuda T; Tanaka O; Hayashi S; Nakahata Y; Yasuda Y; Omatsu T; Obora A; Kojima T; Matsuo M; Yagi N
    Clin J Gastroenterol; 2020 Feb; 13(1):11-16. PubMed ID: 31321737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [FOLFIRI with bevacizumab chemotherapy for a patient with recurrence of rectal cancer under haemodialysis for chronic renal failure].
    Hoshino H; Ishii Y; Hasegawa H; Endo T; Ochiai H; Hoshino Y; Matsunaga A; Shigeta K; Seo Y; Hoshino G; Kitagawa Y
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):983-6. PubMed ID: 22705698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A case of locally advanced colorectal cancer with abscess responding to 5-fluorouracil, leucovorin, and oxaliplatin plus bevacizumab].
    Kuwabara H; Watanabe S; Liu B; Mitsuoka A; Sanada T; Nakajima K; Goseki N
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2032-4. PubMed ID: 24394003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A Case of Rectal Cancer with Unresectable Liver Metastasis Responding to Rechallenge with FOLFIRI].
    Kamiya M; Yoneyama K; Doi Y; Shirai J; Suzuki Y; Hatori S; Yamada T; Sato T; Yamamoto N; Oshima T; Yukawa N; Yoshikawa T; Rino Y; Masuda M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2277-2279. PubMed ID: 28133294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A Case of Successful Collective Treatment of Rectal Cancer Diagnosed by Liver Abscess].
    Kirihara M; Usuda M; Matsutani N; Kobayashi H
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1588-1590. PubMed ID: 36733144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of liver metastasis of rectal cancer, refractory to previous chemotherapy(5-FU/LV, irinotecan, oxaliplatin) responding to bevacizumab combined with FOLFIRI chemotherapy].
    Nishigami K; Kawami H; Yamaguchi T; Yamaguchi K; Kato S
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1765-8. PubMed ID: 19838045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.
    Ochiai T; Masuda T; Yagi M; Kasai R; Furuyama T; Tsukamoto K; Ito H; Igari K; Aihara A; Kumagai Y; Iida M; Odajima H; Tanaka S; Arii S; Yamazaki S
    Int Surg; 2012; 97(1):6-13. PubMed ID: 23101994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A Case of Pathological Complete Response of Advanced Rectal Cancer with Direct Invasion of the Prostate and Extra-Regional Lymph Node Metastasis after Chemotherapy].
    Matsuzawa F; Homma S; Miyaoka Y; Yokoyama R; Nakano S
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1525-1527. PubMed ID: 38303329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of multiple liver metastasis and local recurrence from rectal cancer effectively treated by arterial infusion chemotherapy using low-dose 5-fluorouracil, cisplatin and LV].
    Naitoh H; Okauchi H; Endo Y; Tani T; Kodama M; Yamasaki M
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1764-7. PubMed ID: 9382527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report].
    Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Hasegawa H; Kitagawa Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1834-6. PubMed ID: 24393938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.
    Cremolini C; Loupakis F; Antoniotti C; Lupi C; Sensi E; Lonardi S; Mezi S; Tomasello G; Ronzoni M; Zaniboni A; Tonini G; Carlomagno C; Allegrini G; Chiara S; D'Amico M; Granetto C; Cazzaniga M; Boni L; Fontanini G; Falcone A
    Lancet Oncol; 2015 Oct; 16(13):1306-15. PubMed ID: 26338525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Successful treatment with cetuximab combination chemotherapy in a case of FOLFOX-refractory rectal cancer with previously unresectable multiple liver metastases leading to complete resection].
    Mitsuhashi K; Matsusaka S; Mizunuma N; Ichimura T; Ozaka M; Ogura M; Shinozaki E; Suenaga M; Chin K; Fujimoto Y; Saiura A; Yamamoto N; Hatake K
    Gan To Kagaku Ryoho; 2010 Nov; 37(11):2203-7. PubMed ID: 21084828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of multiple liver metastases from rectal cancer in poor performance status successfully treated with hepatic arterial infusion chemotherapy plus CPT-11].
    Ide Y; Okada K; Ohta H; Maruyama K; Yokouchi H; Kinuta M; Yasumoto T; Murata K
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):2059-61. PubMed ID: 18219898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A Case of Advanced Rectal Cancer Resected Successfully after Induction Chemotherapy with Modified FOLFOX6 plus Panitumumab].
    Yukawa Y; Uchima Y; Kawamura M; Takeda O; Hanno H; Takayanagi S; Hirooka T; Dozaiku T; Hirooka T; Aomatsu N; Hirakawa T; Iwauchi T; Nishii T; Morimoto J; Nakazawa K; Takeuchi K
    Gan To Kagaku Ryoho; 2016 May; 43(5):641-4. PubMed ID: 27210100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.